• MS Medications

  FDA to decide on Ozanimod approval by end of March

  Posted by ed-tobias on March 6, 2020 at 10:41 am

  

  Ozanimod is a new oral DMT and the US Food and Drug Administration is expected to decide by March 25 whether to approve it. It’s the subject of my MS Wire column today.

  ed-tobias replied 4 years, 1 month ago 1 Member · 0 Replies

  • DMT
  • oral MS treatment
  • ozanimod
• 0 Replies

Log In to Reply